Ifp Advisors, Inc Mersana Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$4.63 - $8.0 $8,334 - $14,400	1,800 New	1,800 $36,000
Q3 2021 Oct 06, 2021	SELL	$8.56 - $14.47 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$13.28 - $18.07 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$15.31 - $26.52 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$16.84 - $27.59 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$16.2 - $25.7 $0 - $0	0 New	0 $0

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $211M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.